Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Applovin
APP
|
+$810M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$748M |
| 3 |
Palantir
PLTR
|
+$504M |
| 4 |
Union Pacific
UNP
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$366M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.88B |
| 2 |
Meta Platforms (Facebook)
META
|
+$719M |
| 3 |
Broadcom
AVGO
|
+$683M |
| 4 |
Bank of America
BAC
|
+$675M |
| 5 |
Wells Fargo
WFC
|
+$631M |
Sector Composition
| 1 | Technology | 16.39% |
| 2 | Financials | 13.7% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Cytek Biosciences
CTKB
$501M
| $3.14M | ﹤0.01% |
924,772
+429,335
| +87% | +$1.46M |
|
2277
PrimeEnergy Resources
PNRG
$281M
| $3.14M | ﹤0.01% |
+21,462
| New | +$3.14M |
|
2278
Lazard
LAZ
$5.25B
| $3.14M | ﹤0.01% |
+65,376
| New | +$3.14M |
|
|
GMRE
2279
Global Medical REIT
GMRE
$512M
| $3.13M | ﹤0.01% |
451,967
+125,853
| +39% | +$872K |
|
|
GENVR
2280
Gen Digital Inc. Contingent Value Rights
GENVR
| $3.13M | ﹤0.01% |
+383,592
| New | +$3.13M |
|
2281
Astrana Health
ASTH
$1.38B
| $3.12M | ﹤0.01% |
+125,349
| New | +$3.12M |
|
2282
MidCap Financial Investment
MFIC
$1.16B
| $3.12M | ﹤0.01% |
246,923
+226,362
| +1,101% | +$2.86M |
|
2283
FIGS
FIGS
$1.16B
| $3.11M | ﹤0.01% |
+552,238
| New | +$3.11M |
|
2284
Tecnoglass
TGLS
$3.32B
| $3.11M | ﹤0.01% |
40,203
+12,533
| +45% | +$970K |
|
2285
Travere Therapeutics
TVTX
$2.09B
| $3.09M | ﹤0.01% |
208,991
+149,159
| +249% | +$2.21M |
|
2286
Northeast Community Bancorp
NECB
$270M
| $3.09M | ﹤0.01% |
132,918
-29,998
| -18% | -$697K |
|
2287
Hope Bancorp
HOPE
$1.4B
| $3.08M | ﹤0.01% |
287,201
-204,952
| -42% | -$2.2M |
|
2288
Vertical Aerospace
EVTL
$523M
| $3.08M | ﹤0.01% |
454,478
+367,254
| +421% | +$2.49M |
|
2289
Genius Sports
GENI
$2.98B
| $3.08M | ﹤0.01% |
295,839
-2,470,367
| -89% | -$25.7M |
|
2290
Genco Shipping & Trading
GNK
$774M
| $3.08M | ﹤0.01% |
+235,299
| New | +$3.08M |
|
2291
Terreno Realty
TRNO
$6.05B
| $3.07M | ﹤0.01% |
+54,841
| New | +$3.07M |
|
2292
Vir Biotechnology
VIR
$695M
| $3.07M | ﹤0.01% |
609,292
+175,914
| +41% | +$887K |
|
2293
Nordic American Tanker
NAT
$669M
| $3.07M | ﹤0.01% |
1,166,195
-325,905
| -22% | -$857K |
|
2294
Neuronetics
STIM
$207M
| $3.06M | ﹤0.01% |
878,119
+220,394
| +34% | +$769K |
|
|
TVACU
2295
Texas Ventures Acquisition III Corp Unit
TVACU
| $3.06M | ﹤0.01% |
+300,000
| New | +$3.06M |
|
2296
New Jersey Resources
NJR
$4.74B
| $3.05M | ﹤0.01% |
68,029
-995,565
| -94% | -$44.6M |
|
2297
Silgan Holdings
SLGN
$4.71B
| $3.05M | ﹤0.01% |
56,244
+28,287
| +101% | +$1.53M |
|
2298
Outset Medical
OM
$243M
| $3.05M | ﹤0.01% |
158,535
+43,474
| +38% | +$835K |
|
2299
Itaú Unibanco
ITUB
$75B
| $3.04M | ﹤0.01% |
+448,185
| New | +$3.04M |
|
|
DHC
2300
Diversified Healthcare Trust
DHC
$1.07B
| $3.04M | ﹤0.01% |
849,030
+797,676
| +1,553% | +$2.86M |
|